Construction of the new
London offices of the European Medicines Agency has commenced.
The 500,000 sq ft building at 25 Churchill Place, Canary Wharf will deliver offices spread across 20 floors, with completion scheduled for 2014. The agency last year agreed to pre-let 250,000 sq ft of the available space.
In addition, the premises is the final
London offices site to be constructed under the original Canary Wharf master plan.
Commenting on the news, Canary Wharf Group's managing director of development John Pagano said: "25 Churchill Place will provide a major boost to the local economy, in terms of jobs and contracts and [retain] yet another world-class organisation in central London."
The European Medicines Agency will take up offices across the promenade, ground and the first nine levels. Its rental agreement will begin on January 1st 2015 at a rate of £46.50 per sq ft, while the lease length will stand at 25 years.
No breaks will be allowed under the deal, while an extra four 27,500 sq ft floors can be let further down the line if the organisation requires additional space.
Canary Wharf Group awarded Byrne Bros the concrete contract, while the elevators will be fitted by Kone. Seele will supply and install the cladding.
Two cranes have now been erected at the site of the skyscraper, which was designed by Kohn Pedersen Fox Associates. Canary Wharf Contractors will build the shell and core and conduct the fit out.
Last month, Canary Wharf Group revealed that BNY Mellon had renewed leases for 152,226 sq ft of
central London offices at One Canada Square.
The organisation has extended the leases for eight years at a rent of £42.50 per sq ft, which will kick in from January 1st 2014. The contracts apply to BNY Mellon's space on floors 40 to 41, 43 and 47 to 49 in the 50-storey skyscraper.
Posted by Sarah Dudley
News provided by Adfero in collaboration with Mellersh & Harding. Please note that all copy belongs to (c)Adfero Ltd and does not reflect the views or opinions of Mellersh & Harding unless explicitly stated.
Back